Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.60 |
| ▸ | FNTA | P49354 | 14/20 | 0.51 |
| ▸ | FNTB | P49356 | 12/20 | 0.51 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.51 |
| ▸ | MVD | P53602 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Crotyl Pyrophosphate SCHEMBL14993578 | 1.00 | BTN3A1 (0.60) | BTN3A1FNTAFNTBPGGT1BMVD | |
| SCHEMBL6058114 | 0.87 | BTN3A1 (0.42) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL5852321 | 0.87 | BTN3A1 (0.42) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL23013402 | 0.84 | BTN3A1 (0.43) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL18796260 | 0.84 | BTN3A1 (0.43) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL13268920 | 0.82 | — | — | |
| SCHEMBL1506680 | 0.82 | — | — | |
| SCHEMBL18128306 | 0.82 | BTN3A1 (0.58) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL27930424 | 0.81 | BTN3A1 (0.38) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL28575777 | 0.79 | PPARD (0.38) | BTN3A1FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103842513-B | Process for producing 1, 3-butadiene | 英威达技术有限责任公司 | 2017-05-17 | — | — | CN | claimed |
| US-20160355843-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-12-08 | — | — | US | claimed |
| US-20160355844-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-12-08 | — | — | US | claimed |
| EP-2861745-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | Invista Technologies S.à.r.l. (CH) | 2015-04-22 | — | — | EP | claimed |
| WO-2013188546-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA TECHNOLOGIES S.À.R.L. (CH) | 2013-12-19 | — | — | WO | claimed |
| US-20130189753-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A R.L. (US) | 2013-07-25 | — | — | US | claimed |
| WO-2013071074-A1 | METHODS OF PRODUCING BUTADIENE | INVISTA NORTH AMERICA S.A. R.L. (US) | 2013-05-16 | — | — | WO | claimed |
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | GENOMATICA, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20240294950-A1 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | AGAIN BIO APS (DK) | 2024-09-05 | — | — | US | disclosed |
| EP-4421181-A2 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Genomatica, Inc. (US) | 2024-08-28 | — | — | EP | disclosed |
| EP-4389904-A2 | MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO | Genomatica, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3741865-B1 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | GENOMATICA INC (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-3164495-B1 | MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO | GENOMATICA INC (US) | 2024-02-28 | — | — | EP | disclosed |
| US-20140141482-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA North America S.á r.l. (US) | 2014-05-22 | — | — | US | disclosed |
| US-20130189753-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A R.L. (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2013071074-A1 | METHODS OF PRODUCING BUTADIENE | INVISTA NORTH AMERICA S.A. R.L. (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20110246081-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-06 | — | — | US | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| EP-1109818-A1 | PHOSPHOEPOXIDES, METHOD FOR MAKING SAME AND USES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000012519-A1 | PHOSPHOEPOXIDES, METHOD FOR MAKING SAME AND USES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2000-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | ALDOA, FDPS, DERA | BTN3A1 3958/4885FNTA 147/4885FNTB 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.